H.R. 8160 (119th)Bill Overview

Premenstrual Dysphoric Disorder Awareness and Research Act of 2026

Health|Health
Cosponsors
Support
Democratic
Introduced
Mar 30, 2026
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief

This bill directs HHS/NIH to expand and intensify research on Premenstrual Dysphoric Disorder (PMDD), collect surveillance data, run a public awareness campaign, develop provider education, award training grants, and report to Congress.

It authorizes “such sums as necessary” for fiscal years 2026–2031 for these activities.

Passage40/100

Content is administratively centered and nonpolarizing, improving chances; actual enactment depends on appropriations and Senate floor dynamics.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a substantive policy measure that establishes new programmatic directives for federal health agencies to expand research, surveillance, public education, provider training, and reporting on PMDD. It clearly defines the problem and assigns responsibilities, but leaves many operational, fiscal, and evaluative specifics to agency implementation or future appropriations.

Contention50/100

Funding vagueness: liberals want explicit dollars; conservatives want caps

02 · What it does

Who stands to gain, and who may push back.

Who this appears to help vs burden50% / 50%
Targeted stakeholdersFederal agencies
Likely helped
  • Targeted stakeholdersExpanded research funding could accelerate development of improved PMDD diagnostics and treatments.
  • Targeted stakeholdersProvider education may increase accurate diagnoses and reduce misdiagnosis of PMDD.
  • Targeted stakeholdersPublic awareness campaigns may reduce stigma and increase timely care-seeking.
Likely burdened
  • Federal agenciesThe bill authorizes open-ended federal spending without specified appropriations amounts.
  • Targeted stakeholdersImplementing programs will impose administrative and reporting burdens on HHS, NIH, and HRSA.
  • Targeted stakeholdersUnspecified appropriations risk diverting discretionary funds from other public health priorities.
03 · Why people split

Why the argument around this bill splits.

Funding vagueness: liberals want explicit dollars; conservatives want caps
Progressive85%

Overall supportive: views the bill as addressing an under-researched, stigmatized health condition affecting reproductive-age people.

Sees value in research, provider training, public education, and improved data, but may want stronger commitments on funding, access, and inclusion.

Leans supportive
Centrist75%

Generally favorable but pragmatic: supports research and education for a real medical need while wanting cost controls, outcome measures, and coordination to avoid duplication.

Prefers measurable goals and oversight.

Leans supportive
Conservative40%

Skeptical but not uniformly opposed: may accept targeted research and education, yet worries about federal program expansion, open-ended spending, and bureaucratic growth.

Would press for spending limits and state/family authority protections.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Content is administratively centered and nonpolarizing, improving chances; actual enactment depends on appropriations and Senate floor dynamics.

Scope and complexity
52%
Scopemoderate
24%
Complexitylow
Why this could stall
  • No cost estimate or fiscal magnitude provided
  • Actual funding depends on future appropriations decisions
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Funding vagueness: liberals want explicit dollars; conservatives want caps

Content is administratively centered and nonpolarizing, improving chances; actual enactment depends on appropriations and Senate floor dyna…

Unlocked analysis

Relative to its intended legislative type, this bill is a substantive policy measure that establishes new programmatic directives for federal health agencies to expand research, surveillance, public education, provider…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis